DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/535vcq/cystic_fibrosis) has announced the addition of the "Cystic Fibrosis Pipeline Highlights - 2015" report to their offering.
The latest report Cystic Fibrosis Pipeline Highlights - 2015, provides most up-to-date information on key pipeline molecules in the global Cystic Fibrosis market. It covers emerging therapies for Cystic Fibrosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Cystic Fibrosis pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Cystic Fibrosis pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Cystic Fibrosis pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which Cystic Fibrosis pipeline products will be launched in the US and Ex-US till 2017.
Key Topics Covered:
1. Cystic Fibrosis Pipeline by Stages
2. Cystic Fibrosis Pipeline by Drug Class
3. Cystic Fibrosis Pipeline by Company
4. Cystic Fibrosis Phase 3 Clinical Trial Insights
5. Cystic Fibrosis Phase 2 Clinical Trial Insights
6. Cystic Fibrosis Phase 1 Clinical Trial Insights
7. Cystic Fibrosis Preclinical Research Insights
8. Cystic Fibrosis Discovery Stage Insights
10. Research Methodology
For more information visit http://www.researchandmarkets.com/research/535vcq/cystic_fibrosis